NUP98
Nuclear pore complex protein Nup98-Nup96
Also known as: NUP196, NUP96, NUP98_HUMAN, Nup98-96, Nup98-Nup96
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P52948
- Gene
- NUP98
- Ensembl
- ENSG00000110713
- Chromosome
- 11
- Canonical length
- 1817 aa
- Protein class
- Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
Nuclear pore complexes (NPCs) regulate the transport of macromolecules between the nucleus and cytoplasm, and are composed of many polypeptide subunits, many of which belong to the nucleoporin family. This gene belongs to the nucleoporin gene family and encodes a 186 kDa precursor protein that undergoes autoproteolytic cleavage to generate a 98 kDa nucleoporin and 96 kDa nucleoporin. The 98 kDa nucleoporin contains a Gly-Leu-Phe-Gly (GLGF) repeat domain and participates in many cellular processes, including nuclear import, nuclear export, mitotic progression, and regulation of gene expression. The 96 kDa nucleoporin is a scaffold component of the NPC. Proteolytic cleavage is important for targeting of the proteins to the NPC. Translocations between this gene and many other partner genes have been observed in different leukemias. Rearrangements typically result in chimeras with the N-terminal GLGF domain of this gene to the C-terminus of the partner gene. Alternative splicing results in multiple transcript variants encoding different isoforms, at least two of which are proteolytically processed. Some variants lack the region that encodes the 96 kDa nucleoporin. [provided by RefSeq, Feb 2016]
Canonical amino-acid sequenceUniProt
1817 residues, UniProt reviewed canonical sequence.
>P52948|NUP98
1 MFNKSFGTPF GGGTGGFGTT STFGQNTGFG TTSGGAFGTS AFGSSNNTGG LFGNSQTKPG
61 GLFGTSSFSQ PATSTSTGFG FGTSTGTANT LFGTASTGTS LFSSQNNAFA QNKPTGFGNF
121 GTSTSSGGLF GTTNTTSNPF GSTSGSLFGP SSFTAAPTGT TIKFNPPTGT DTMVKAGVST
181 NISTKHQCIT AMKEYESKSL EELRLEDYQA NRKGPQNQVG AGTTTGLFGS SPATSSATGL
241 FSSSTTNSGF AYGQNKTAFG TSTTGFGTNP GGLFGQQNQQ TTSLFSKPFG QATTTQNTGF
301 SFGNTSTIGQ PSTNTMGLFG VTQASQPGGL FGTATNTSTG TAFGTGTGLF GQTNTGFGAV
361 GSTLFGNNKL TTFGSSTTSA PSFGTTSGGL FGNKPTLTLG TNTNTSNFGF GTNTSGNSIF
421 GSKPAPGTLG TGLGAGFGTA LGAGQASLFG NNQPKIGGPL GTGAFGAPGF NTTTATLGFG
481 APQAPVALTD PNASAAQQAV LQQHINSLTY SPFGDSPLFR NPMSDPKKKE ERLKPTNPAA
541 QKALTTPTHY KLTPRPATRV RPKALQTTGT AKSHLFDGLD DDEPSLANGA FMPKKSIKKL
601 VLKNLNNSNL FSPVNRDSEN LASPSEYPEN GERFSFLSKP VDENHQQDGD EDSLVSHFYT
661 NPIAKPIPQT PESAGNKHSN SNSVDDTIVA LNMRAALRNG LEGSSEETSF HDESLQDDRE
721 EIENNSYHMH PAGIILTKVG YYTIPSMDDL AKITNEKGEC IVSDFTIGRK GYGSIYFEGD
781 VNLTNLNLDD IVHIRRKEVV VYLDDNQKPP VGEGLNRKAE VTLDGVWPTD KTSRCLIKSP
841 DRLADINYEG RLEAVSRKQG AQFKEYRPET GSWVFKVSHF SKYGLQDSDE EEEEHPSKTS
901 TKKLKTAPLP PASQTTPLQM ALNGKPAPPP QSQSPEVEQL GRVVELDSDM VDITQEPVLD
961 TMLEESMPED QEPVSASTHI ASSLGINPHV LQIMKASLLT DEEDVDMALD QRFSRLPSKA
1021 DTSQEICSPR LPISASHSSK TRSLVGGLLQ SKFTSGAFLS PSVSVQECRT PRAASLMNIP
1081 STSSWSVPPP LTSVFTMPSP APEVPLKTVG TRRQLGLVPR EKSVTYGKGK LLMDMALFMG
1141 RSFRVGWGPN WTLANSGEQL NGSHELENHQ IADSMEFGFL PNPVAVKPLT ESPFKVHLEK
1201 LSLRQRKPDE DMKLYQTPLE LKLKHSTVHV DELCPLIVPN LGVAVIHDYA DWVKEASGDL
1261 PEAQIVKHWS LTWTLCEALW GHLKELDSQL NEPREYIQIL ERRRAFSRWL SCTATPQIEE
1321 EVSLTQKNSP VEAVFSYLTG KRISEACSLA QQSGDHRLAL LLSQFVGSQS VRELLTMQLV
1381 DWHQLQADSF IQDERLRIFA LLAGKPVWQL SEKKQINVCS QLDWKRSLAI HLWYLLPPTA
1441 SISRALSMYE EAFQNTSDSD RYACSPLPSY LEGSGCVIAE EQNSQTPLRD VCFHLLKLYS
1501 DRHYDLNQLL EPRSITADPL DYRLSWHLWE VLRALNYTHL SAQCEGVLQA SYAGQLESEG
1561 LWEWAIFVLL HIDNSGIREK AVRELLTRHC QLLETPESWA KETFLTQKLR VPAKWIHEAK
1621 AVRAHMESDK HLEALCLFKA EHWNRCHKLI IRHLASDAII NENYDYLKGF LEDLAPPERS
1681 SLIQDWETSG LVYLDYIRVI EMLRHIQQVD CSGNDLEQLH IKVTSLCSRI EQIQCYSAKD
1741 RLAQSDMAKR VANLLRVVLS LHHPPDRTSD STPDPQRVPL RLLAPHIGRL PMPEDYAMDE
1801 LRSLTQSYLR ELAVGSLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NUP98 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 67 nTPM
Expression across tissuesHPA
Tissue
- testis: 67 nTPM
- bone marrow: 46 nTPM
- skeletal muscle: 40 nTPM
- liver: 32 nTPM
- tongue: 29 nTPM
- thymus: 28 nTPM
Single-cell type
- neutrophils: 1,825 nCPM
- neutrophil progenitors: 361 nCPM
- monocytes: 299 nCPM
- megakaryocyte-erythroid progenitors: 275 nCPM
- cardiomyocytes: 254 nCPM
- late spermatids: 250 nCPM
Immune cell
- basophil: 30 nTPM
- neutrophil: 30 nTPM
- eosinophil: 18 nTPM
- T-reg: 16 nTPM
- MAIT T-cell: 13 nTPM
- naive CD4 T-cell: 13 nTPM
Brain region
- choroid plexus: 31 nTPM
- cerebellum: 30 nTPM
- white matter: 29 nTPM
- cerebral cortex: 25 nTPM
- midbrain: 25 nTPM
- thalamus: 25 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NUP98.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 291 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.12
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.41
- DepMap mean gene effect
- -0.92
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- mRNA transport
- nuclear pore complex assembly
- nuclear pore organization
- nucleocytoplasmic transport
- positive regulation of mRNA splicing, via spliceosome
- post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery
- protein import into nucleus
- proteolysis
- RNA export from nucleus
- telomere tethering at nuclear periphery
Molecular functions
- molecular condensate scaffold activity
- mRNA binding
- nuclear localization sequence binding
- promoter-specific chromatin binding
- RNA binding
- serine-type peptidase activity
- structural constituent of nuclear pore
- transcription coactivator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Nuclear pore complex protein Nup98-Nup96-like, autopeptidase S59 domain
- Nuclear pore complex protein NUP96, C-terminal domain
- Nuclear pore complex protein Nup98-Nup96-like, autopeptidase S59 domain superfamily
- Nucleoporin peptidase S59-like
- Nup98-96 autopeptidase S59
- Nuclear protein 96
- Nup98, Gle2-binding sequence
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NUP98 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NUP98 as an antibody target. Whether an autoantibody or antibody against NUP98 could matter depends on whether native NUP98 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NUP98 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NUP98 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...